Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Expression signatures of long non-coding RNAs in Left ventricular Noncompaction

ABSTRACT: Expression signatures of long non-coding RNAs in Left ventricular Noncompaction

PROVIDER: PRJNA739684 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Similar Datasets

Expression signatures of long non-coding RNAs in Left ventricular Noncompaction

Project description:This result may predict some lncRNA as disease-specific biomarkers of LVNC, shed light on the development of LVNC diseases, and provide useful information for exploring potential therapeutic

2021-09-19 | GSE178582 | GEO

Left ventricular apex samples

Project description:19 paired human left ventricular apex samples were harvested at the time of implant of a left ventricular assist device (PRE) and at the time of explant (POST). The cohort included patients that were clinically classified as "ischemic" (I) showing evidence of coronary artery disease, "non-ischemic" (N) no evidence of coronary artery disease or "acute Myocardial infarction" (IM) myocardial infarction within 10 days of the implant. Tissue was processed and hybridized to the Affymetrix HG-U133A chip. Keywords: other

2004-01-18 | GSE974 | GEO

Expression Signatures of Long Noncoding RNAs in Left Ventricular Noncompaction.

Project description:Long noncoding RNAs have gained widespread attention in recent years for their crucial role in biological regulation. They have been implicated in a range of developmental processes and diseases including cancer, cardiovascular, and neuronal diseases. However, the role of long noncoding RNAs (lncRNAs) in left ventricular noncompaction (LVNC) has not been explored. In this study, we investigated the expression levels of lncRNAs in the blood of LVNC patients and healthy subjects to identify differentially expressed lncRNA that develop LVNC specific biomarkers and targets for developing therapies using biological pathways. We used Agilent Human lncRNA array that contains both updated lncRNAs and mRNAs probes. We identified 1,568 upregulated and 1,141 downregulated (log fold-change > 2.0) lncRNAs that are differentially expressed between LVNC and the control group. Among them, RP11-1100L3.7 and XLOC_002730 are the most upregulated and downregulated lncRNAs. Using quantitative real-time reverse transcription polymerase chain reaction (RT-QPCR), we confirmed the differential expression of three top upregulated and downregulated lncRNAs along with two other randomly picked lncRNAs. Gene Ontology (GO) and KEGG pathways analysis with these differentially expressed lncRNAs provide insight into the cellular pathway leading to LVNC pathogenesis. We also identified 1,066 upregulated and 1,017 downregulated mRNAs. Gene set enrichment analysis (GSEA) showed that G2M, Estrogen, and inflammatory pathways are enriched in differentially expressed genes (DEG). We also identified miRNA targets for these differentially expressed genes. In this study, we first report the use of LncRNA microarray to understand the pathogenesis of LVNC and to identify several lncRNA and genes and their targets as potential biomarkers.

| S-EPMC8631435 | biostudies-literature

Transcription profiling of human left ventricular apex samples

Project description:19 paired human left ventricular apex samples were harvested at the time of implant of a left ventricular assist device (PRE) and at the time of explant (POST). The cohort included patients that were clinically classified as ischemic (I) showing evidence of coronary artery disease, non-ischemic (N) no evidence of coronary artery disease or acute Myocardial infarction (IM) myocardial infarction within 10 days of the implant. Tissue was processed and hybridized to the Affymetrix HG-U133A chip.

2007-10-02 | E-GEOD-974 | biostudies-arrayexpress

Effect of left ventricular assist device support on congestive heart failure patients

Project description:Molecular analysis of the effect left ventricular assist device (LVAD) support has on congestive heart failure patients. Keywords = Congestive heart failure, left ventricular assist device, eNOS, gene, dimethylarginine dimethylaminohydrolase Keywords: other

2003-09-01 | GSE430 | GEO

NHLBI TOPMed: HyperGEN: Genetics of Left Ventricular Hypertrophy

Project description:NHLBI TOPMed: HyperGEN: Genetics of Left Ventricular Hypertrophy

| PRJNA371675 | ENA

TRanscriptomic ANalySis of left ventriCulaR gene Expression (TRANSCRibE)

Project description:TRanscriptomic ANalySis of left ventriCulaR gene Expression (TRANSCRibE)

| PRJNA488857 | ENA

TRanscriptomic ANalySis of left ventriCulaR gene Expression (TRANSCRibE)

Project description:TRanscriptomic ANalySis of left ventriCulaR gene Expression (TRANSCRibE)

| PRJNA488858 | ENA

Plasma circulating extracellular RNAs in left ventricular remodeling post-myocardial infarction

Project description:Plasma circulating extracellular RNAs in left ventricular remodeling post-myocardial infarction

| PRJNA448747 | ENA

Oestrogen effects on the left ventricular transcriptome of healhty mice

Project description:Comparison of mouse left ventricular responses to oestrogen with control.

2014-04-10 | E-MEXP-3834 | biostudies-arrayexpress

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data